ACTB and neoplasm: More importantly, the expression level of SUMO1/2 was negatively correlated with the infiltration levels of a variety of tumor-infiltrating immune cells, including Act B, Imm B, and Tem CD8, and with most immune modulators (immune promoters, MHC molecules, chemokines, and chemokine receptors).